Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE
about
New treatment options against gram-negative organismsPurification and characterization of a novel lipopeptide from Streptomyces amritsarensis sp. nov. active against methicillin-resistant Staphylococcus aureusSignature motifs identify an Acinetobacter Cif virulence factor with epoxide hydrolase activity10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaCombating antimicrobial resistance: policy recommendations to save livesThe impact of malaria parasitism: from corpuscles to communitiesThree decades of beta-lactamase inhibitorsInsights into Bacteriophage Application in Controlling Vibrio SpeciesAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Focal Targeting of the Bacterial Envelope by Antimicrobial PeptidesMechanisms of Antimicrobial Resistance in ESKAPE PathogensDiversity, evolution and medical applications of insect antimicrobial peptidesIntrigues of biofilm: A perspective in veterinary medicine.Electrophysiological Monitoring of Brain Injury and Recovery after Cardiac ArrestAntibacterial Discovery and Development: From Gene to Product and BackAntibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature reviewNext-generation antimicrobials: from chemical biology to first-in-class drugsCan we prevent antimicrobial resistance by using antimicrobials better?Acinetobacter baumannii: an emerging opportunistic pathogenAdult calcaneal osteitis: incidence, etiology, diagnostics and therapyGram negative wound infection in hospitalised adult burn patients--systematic review and metanalysis-Antimicrobial photodynamic therapy to kill Gram-negative bacteriaHealthcare-associated infections, infection control and the potential of new antibiotics in development in the USACode blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavityCeftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combinationThere should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacyThe human gut resistomeEndophytic fungi: a reservoir of antibacterialsMolecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound CenterSimulating Serial-Target Antibacterial Drug Synergies Using Flux Balance AnalysisMultiple-omic data analysis of Klebsiella pneumoniae MGH 78578 reveals its transcriptional architecture and regulatory featuresA potent synthetic inorganic antibiotic with activity against drug-resistant pathogensCrystal structure of the flavoenzyme PA4991 from Pseudomonas aeruginosaBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaBacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of BacteremiaA novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteriaComparative metabolic systems analysis of pathogenic BurkholderiaCould chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption.Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?
P2860
Q21194906-AB8C4949-9EDA-41FA-BDE1-4E1CB2BE3833Q21999339-DB6E7129-4745-49A4-BA06-1E4EBC35B29AQ24568297-AFE05926-A79D-4235-8D29-ABF15490DF8CQ24601746-E716A41C-3E68-4D8E-8374-286446CDBB02Q24632857-C86608ED-73C1-4D34-834C-C6602B9870E2Q24644343-3C29AC2E-69E9-459A-8BE2-998E4BCDC6F6Q24646623-0C2A5E2A-9A69-42C5-AC39-E9FE19C0FC2BQ26739744-2C3B22E7-4A3D-4260-BE74-81DF22966A23Q26739860-90B70EB0-2009-4515-8EFB-551E220B8F0DQ26744785-47E611EB-17D5-4A59-B035-3F3AE8EF7DD9Q26747594-D6CE61B2-0A6A-4DB2-82C5-6514C56069F8Q26751067-C549F122-DAFC-4867-96EF-DF65C0EC8241Q26751336-67A41FD4-FEE8-4BEB-93C3-FFD5A1F8B550Q26777071-A50CA6BC-CEC9-4267-AE59-F9F0EB68B074Q26784492-D7AFD3A7-1980-47D7-9CEB-9EB0E1778AB2Q26796605-B8AA5A44-6686-4BD9-AFE1-48F54AE69994Q26799749-4C28919D-D26C-4000-93FE-A8146250F46CQ26829707-56DAA39F-E416-48DA-9D88-97A9A328912DQ26830893-3FB399A6-A2AF-40B4-A787-291B79C5C569Q26860304-42D396E7-7D44-4122-A9EA-1B2C66558252Q26864465-D6625AEB-1FAF-41FD-B7F0-F13FACC6C315Q26866247-9211FC63-D931-4BD7-AFBC-0D7A2EED61E9Q26995305-CDBC643E-5FAF-4F06-AA47-B32147102C1EQ26996396-93D97192-17E9-4D1C-BA0E-C4A674ACA732Q26998883-5FA199A7-3AF8-408C-84CE-095A56B0131DQ27005826-D4ED888F-8847-4122-A9C2-DC60DED4C694Q27027882-BBC48306-6696-4752-AB42-73E949CA4A5BQ28083549-AEB81FF4-FEDA-4F86-A4D8-8444AE213B96Q28552411-0D88BAAF-D52B-4E74-9903-3FBB478F32FAQ28552960-8B1D69A2-CECB-4637-A92F-3F964521AAB2Q28710105-A15B9C84-BF0E-4D63-99E3-07EB1357430CQ28817444-E6795D65-D34F-4052-A697-69AF364EC849Q29465375-E17E3B25-76F8-4ADA-8577-D72D3405BA95Q29616084-2A7A1695-1B0B-4A07-919F-D8D25A706088Q30401003-6303F27A-3864-4C5B-9B83-3EE8CC243577Q30410098-3DFDBEC0-9992-4F3E-8CD5-061D70C06846Q30412173-57CB1654-CC34-40EA-AD23-8D0063144F5FQ30726683-25D7E1B5-681F-4D6A-81ED-A965235BBB8CQ30795809-88498410-EC0A-4B70-98D2-C0AB6863BA23Q31004673-FB362188-8C9E-4747-8179-A212641A734D
P2860
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@ast
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@en
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@nl
type
label
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@ast
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@en
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@nl
prefLabel
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@ast
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@en
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@nl
P3181
P356
P1476
Federal funding for the study ...... osocomial pathogens: no ESKAPE
@en
P2093
Louis B Rice
P304
P3181
P356
10.1086/533452
P407
P577
2008-04-15T00:00:00Z